COMMUNIQUÉS West-GlobeNewswire

Capital Senior Living Corporation Reports First Quarter 2018 Results

01/05/2018 - 22:15

DALLAS, May 01, 2018 (GLOBE NEWSWIRE) -- Capital Senior Living Corporation (the “Company”) (NYSE: CSU ), one of the nation’s largest operators of senior housing communities, today announced operating and financial [...]

TESARO Announces Participation in Two Investor Conferences

01/05/2018 - 22:15

WALTHAM, Mass., May 01, 2018 (GLOBE NEWSWIRE) -- TESARO, Inc. (NASDAQ: TSRO ), an oncology-focused biopharmaceutical company, today announced its participation in two upcoming investor conferences. The two conferences [...]

Prothena to Report First Quarter 2018 Financial Results on May 8

01/05/2018 - 22:05

DUBLIN, Ireland, May 01, 2018 (GLOBE NEWSWIRE) -- Prothena Corporation plc (Nasdaq: PRTA ), a clinical-stage biotechnology company focused on the discovery and development of novel therapies in the neuroscience and [...]

resTORbio to Present at the Deutsche Bank 43rd Annual Health Care Conference

01/05/2018 - 22:05

BOSTON, May 01, 2018 (GLOBE NEWSWIRE) -- resTORbio, Inc. (NASDAQ: TORC ), a clinical-stage biopharmaceutical company focused on helping people live healthier longer through the development and commercialization of novel [...]

K2M Group Holdings, Inc. Reports First Quarter 2018 Financial Results and Updates Fiscal Year 2018 Outlook

01/05/2018 - 22:05

LEESBURG, Va., May 01, 2018 (GLOBE NEWSWIRE) -- K2M Group Holdings, Inc. (Nasdaq: KTWO ) (the “Company” or “K2M”), a global leader of complex spine and minimally invasive solutions focused on achieving three-dimensional [...]

Pernix Therapeutics to Report First Quarter 2018 Financial Results on Thursday, May 10

01/05/2018 - 22:05

MORRISTOWN, N.J., May 01, 2018 (GLOBE NEWSWIRE) -- Pernix Therapeutics Holdings, Inc. (NASDAQ: PTX ), a specialty pharmaceutical company, announced today that the Company will report financial results for the first [...]

Sunesis Pharmaceuticals to Host Conference Call on May 8th to Discuss First Quarter 2018 Financial Results and Recent Highlights

01/05/2018 - 22:05

SOUTH SAN FRANCISCO, Calif., May 01, 2018 (GLOBE NEWSWIRE) -- Sunesis Pharmaceuticals, Inc. (Nasdaq: SNSS ) today announced that it will host a conference call on Tuesday, May 8 th , 2018 at 4:30 p.m. Eastern Time to [...]

Corcept Therapeutics to Announce First Quarter Financial Results, Provide Corporate Update and Host Conference Call

01/05/2018 - 22:05

MENLO PARK, Calif., May 01, 2018 (GLOBE NEWSWIRE) -- Corcept Therapeutics Incorporated (NASDAQ: CORT ) today announced it will report first quarter financial results and provide a corporate update on May 8, 2018. The [...]

GenMark Diagnostics Reports First Quarter 2018 Results

01/05/2018 - 22:05

CARLSBAD, Calif., May 01, 2018 (GLOBE NEWSWIRE) -- GenMark Diagnostics, Inc. (Nasdaq: GNMK ), a leading provider of automated, multiplex molecular diagnostic testing systems, today announced financial results for the [...]

SIGA Technologies Announces Favorable Outcome of Advisory Committee In Support of TPOXX®

01/05/2018 - 22:03

NEW YORK, May 01, 2018 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. (SIGA) (NASDAQ: SIGA ), a health security company specializing in the development and commercialization of solutions for serious unmet medical needs and [...]

Galapagos and MorphoSys announce initiation of the IGUANA Phase 2 clinical trial with MOR106 in atopic dermatitis patients

01/05/2018 - 22:02

Mechelen, Belgium and Planegg/Munich, Germany; 1 May 2018; 22.01 CET - Galapagos NV (Euronext & NASDAQ: GLPG) and MorphoSys AG (FSE: MOR; Prime Standard Segment, TecDAX; OTC: MPSYY) announced today that the first [...]

Dermira to Present at Deutsche Bank 43rd Annual Healthcare Conference

01/05/2018 - 22:02

MENLO PARK, Calif., May 01, 2018 (GLOBE NEWSWIRE) -- Dermira, Inc. (NASDAQ: DERM ), a biopharmaceutical company dedicated to bringing biotech ingenuity to medical dermatology by delivering differentiated, new therapies [...]

Mersana Therapeutics to Present at the Deutsche Bank 43rd Annual Health Care Conference

01/05/2018 - 22:01

CAMBRIDGE, Mass., May 01, 2018 (GLOBE NEWSWIRE) -- Mersana Therapeutics, Inc. (NASDAQ: MRSN ), a clinical-stage biopharmaceutical company focused on discovering and developing a pipeline of antibody drug conjugates ( [...]

Paratek Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

01/05/2018 - 22:01

BOSTON, May 01, 2018 (GLOBE NEWSWIRE) -- Paratek Pharmaceuticals, Inc. (Nasdaq: PRTK ), a biopharmaceutical company focused on the development and commercialization of innovative therapies based upon tetracycline [...]

Teladoc Announces First Quarter 2018 Results

01/05/2018 - 22:01

1Q 2018 Revenue of $89.6 million, growth of 109% Total Paid Membership of 20.8 million, growth of 41% 1Q 2018 Total Visits of 606,000, growth of 57% PURCHASE, NY, May 01, 2018 (GLOBE NEWSWIRE) -- Teladoc, Inc. (NYSE: [...]

Xenon Pharmaceuticals to Host Conference Call and Webcast to Discuss First Quarter 2018 Financial Results and Provide Corporate Update

01/05/2018 - 22:01

BURNABY, British Columbia, May 01, 2018 (GLOBE NEWSWIRE) -- Xenon Pharmaceuticals Inc. (Nasdaq: XENE ), a clinical-stage biopharmaceutical company, today announced that it will report its first quarter 2018 financial [...]

Retrophin Reports First Quarter 2018 Financial Results

01/05/2018 - 22:01

Company obtains FDA and EMA feedback on pathway to NDA and MAA filing for sparsentan in IgA nephropathy; single Phase 3 trial expected to initiate in the fourth quarter of 2018 Pivotal Phase 3 DUPLEX Study of sparsentan [...]

Trevena Inc. and Jiangsu Nhwa Pharmaceutical Co. Ltd Announce License Agreement for Oliceridine in China

01/05/2018 - 22:01

– Nhwa granted a license to develop, manufacture, and commercialize oliceridine in China – – Trevena to receive upfront and milestone payments and royalties – CHESTERBROOK, Pa. and XUZHOU, China, May 01, 2018 (GLOBE [...]

CytomX Therapeutics to Announce First Quarter 2018 Financial Results

01/05/2018 - 22:01

SOUTH SAN FRANCISCO, Calif., May 01, 2018 (GLOBE NEWSWIRE) -- CytomX Therapeutics, Inc. (Nasdaq: CTMX ), a clinical-stage biopharmaceutical company developing investigational Probody™ therapeutics for the treatment of [...]